BioNTech SE BNTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 02/06/23 EST
140.96quote price arrow down-1.10 (-0.77%)
Volume
311,876
52 week range
117.08 - 188.99
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close140.96
  • 52 Week High188.99
  • 52 Week High Date12/15/22
  • 52 Week Low117.08
  • 52 Week Low Date06/22/22

Key Stats

  • Market Cap34.209B
  • Shares Out242.69M
  • 10 Day Average Volume0.60M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change-6.16

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close140.96
  • 52 Week High188.99
  • 52 Week High Date12/15/22
  • 52 Week Low117.08
  • 52 Week Low Date06/22/22
  • Market Cap34.209B
  • Shares Out242.69M
  • 10 Day Average Volume0.60M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change-6.16

RATIOS/PROFITABILITY

  • EPS (TTM)39.99
  • P/E (TTM)3.52
  • Fwd P/E (NTM)7.84
  • EBITDA (TTM)13.926B
  • ROE (TTM)76.24%
  • Revenue (TTM)20.037B
  • Gross Margin (TTM)81.71%
  • Net Margin (TTM)55.60%
  • Debt To Equity (MRQ)1.49%

EVENTS

  • Earnings Date03/30/2023(est)
  • Ex Div Date06/02/2022
  • Div Amount2.1322
  • Split Date-
  • Split Factor-

Latest On BioNTech SE

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific...
Ugur Sahin M.D.
Chief Executive Officer, Member of the Management Board
Sierk Poetting
Chief Operating Officer, Member of the Management Board
Jens Holstein
Chief Financial Officer
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
BIIB
Biogen Inc
288.28+4.65+1.64%
MRNA
Moderna Inc
170.27-2.98-1.72%
ILMN
Illumina Inc
208.70-5.56-2.59%
ALNY
Alnylam Pharmaceuticals Inc
224.14-9.23-3.96%
REGN
Regeneron Pharmaceuticals Inc
780.86-2.27-0.29%